Yubo International Biotech annual net debt
2020
2021
2022
2023
2024
2025
Yubo International Biotech Net Debt Growth & History (YBGJ)
Yubo International Biotech's net debt was $70,720 for fiscal 2025.
View full Yubo International Biotech company overviewYubo International Biotech annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $70,720 | −$401,030 | −85.01% |
| 2024 | 2024-12-31 | $471,750 | $86,196 | +22.36% |
| 2023 | 2023-12-31 | $385,554 | −$386,725 | −50.08% |
| 2022 | 2022-12-31 | $772,279 | $505,811 | +189.82% |
| 2021 | 2021-12-31 | $266,468 | $1.3M | — |
| 2020 · Dec 31 | 2020-12-31 | −$1.1M | — | — |
Yubo International Biotech quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3,666 | −$170,811 | −97.90% |
| Q1 2026 | 2026-03-31 | $28,833 | −$192,801 | −86.99% |
| Q4 2025 | 2025-12-31 | $70,720 | −$401,030 | −85.01% |
| Q3 2025 | 2025-09-30 | $127,678 | −$443,732 | −77.66% |
| Q2 2025 | 2025-06-30 | $174,477 | −$316,835 | −64.49% |
| Q1 2025 | 2025-03-31 | $221,634 | −$12,940 | −5.52% |
| Q4 2024 | 2024-12-31 | $471,750 | $86,196 | +22.36% |
| Q3 2024 | 2024-09-30 | $571,410 | $85,924 | +17.70% |
| Q2 2024 | 2024-06-30 | $491,312 | −$63,995 | −11.52% |
| Q1 2024 | 2024-03-31 | $234,574 | −$402,242 | −63.16% |
| Q4 2023 | 2023-12-31 | $385,554 | −$386,725 | −50.08% |
| Q3 2023 | 2023-09-30 | $485,486 | $267,674 | +122.89% |
| Q2 2023 | 2023-06-30 | $555,307 | $290,850 | +109.98% |
| Q1 2023 | 2023-03-31 | $636,816 | $339,439 | +114.14% |
| Q4 2022 | 2022-12-31 | $772,279 | $505,811 | +189.82% |
| Q3 2022 | 2022-09-30 | $217,812 | $201,372 | +1224.89% |
| Q2 2022 | 2022-06-30 | $264,457 | −$162,069 | −38.00% |
| Q1 2022 | 2022-03-31 | $297,377 | $192,426 | +183.35% |
| Q4 2021 | 2021-12-31 | $266,468 | $1.3M | — |
| Q3 2021 · Sep 30 | 2021-09-30 | $16,440 | — | — |
| Q2 2021 · Jun 30 | 2021-06-30 | $426,526 | — | — |
| Q1 2021 · Mar 31 | 2021-03-31 | $104,951 | — | — |
| Q4 2020 · Dec 31 | 2020-12-31 | −$1.1M | — | — |
Yubo International Biotech net debt trends
Over the last five fiscal years, Yubo International Biotech's net debt increased from −$1.1M to $70,720, a change of $1.1M. The latest reported quarter, Q2 2026, shows $3,666.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Yubo International Biotech source filings ↗